000 01119 a2200313 4500
005 20250515035303.0
264 0 _c20061017
008 200610s 0 0 eng d
022 _a1087-0156
024 7 _a10.1038/nbt1234
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPapadopoulos, Nickolas
245 0 0 _aThe role of companion diagnostics in the development and use of mutation-targeted cancer therapies.
_h[electronic resource]
260 _bNature biotechnology
_cAug 2006
300 _a985-95 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aGene Targeting
_xmethods
650 0 4 _aGenetic Predisposition to Disease
_xgenetics
650 0 4 _aGenetic Testing
_xmethods
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aHumans
650 0 4 _aMolecular Diagnostic Techniques
_xmethods
650 0 4 _aMutation
650 0 4 _aNeoplasms
_xdiagnosis
700 1 _aKinzler, Kenneth W
700 1 _aVogelstein, Bert
773 0 _tNature biotechnology
_gvol. 24
_gno. 8
_gp. 985-95
856 4 0 _uhttps://doi.org/10.1038/nbt1234
_zAvailable from publisher's website
999 _c16487901
_d16487901